R O Escárcega, M Garcia-Carrasco, L J Jara, R Cervera. Show Affiliations »
Abstract
Entities: Disease
Mesh： See more » Aspirin/therapeutic useAzetidines/therapeutic useClinical Trials as TopicCoronary Artery Disease/complicationsCoronary Artery Disease/drug therapyCoronary Artery Disease/physiopathologyDrug Therapy, CombinationEzetimibeHumansHydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic useLupus Erythematosus, Systemic/complicationsLupus Erythematosus, Systemic/drug therapyMyocardial Infarction/prevention & controlPlatelet Aggregation Inhibitors/therapeutic useRisk
Substances： See more » AzetidinesHydroxymethylglutaryl-CoA Reductase InhibitorsPlatelet Aggregation InhibitorsEzetimibeAspirin
Year: 2009 PMID： 19318388 DOI： 10.1177/0961203308101435
Source DB: PubMed Journal: Lupus ISSN： 0961-2033 Impact factor: 2.911